PHARMACOLOGICAL ANTAGONISM OF THE INCRETIN SYSTEM PROTECTS AGAINST DIET-INDUCED OBESITY

[pdf-embedder url=»https://www.sochob.cl/web1/wp-content/uploads/2020/02/Pharmacological-antagonism-of-the-incretin-system-protects-against-diet-induced-obesity.pdf» title=»Pharmacological antagonism of the incretin system protects against diet-induced obesity»]

Physical exercise and liver “fitness”: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease Regulation of muscle and metabolic physiology by hypothalamic erythropoietin independently of its peripheral action